Co-Diagnostics Q3: Cash Falls to $715K, Going Concern Reaffirmed, J.J. Astor Loan Sweeps ATM Proceeds
CODX sits 17% above its 52-week low of $0.245 on elevated volume (37× avg).
Summary
Co-Diagnostics ended Q3 with $714,803 of cash, reaffirmed going concern doubt, and disclosed a post-quarter J.J. Astor convertible loan whose terms divert ATM proceeds to the lender.
Key Events · Earnings and Guidance · CODX
-
Q3 Loss of $6.31M on $283K Revenue
Three-month net loss was $6,306,408, or $1.01 per share, on product revenue of $282,881; nine-month net loss reached $21,730,232.
-
Cash Falls to $715K, Going Concern Reaffirmed
Cash and cash equivalents were $714,803 at September 30, 2026 versus $11,884,607 at December 31, 2025, against $2,511,820 of current liabilities. Management concluded substantial doubt exists about the ability to continue as a going concern for 12 months.
-
J.J. Astor Loan Diverts ATM Proceeds
The October 9, 2026 loan funded $2.1 million against a $2.835 million note (1.35x factor) with a 4% origination fee and $250,000 minimum cash covenant; 100% of ATM net proceeds go to the lender until $1.0 million is paid, then 80% to the note.
-
600,000 Commitment Shares With Make-Whole
The company issued the lender 600,000 shares at closing, with additional make-whole shares owed if those shares are sold below $0.218.
Analysis · CODX · Industrial Applications And Services
Cash and equivalents dropped to $714,803 at September 30 from $11,884,607 at the start of the year, against $2,511,820 of current liabilities — the company is now funding itself quarter to quarter. Management again concluded substantial doubt exists about continuing as a going concern for 12 months, and the only new money since quarter-end is a $2.1 million J.J. Astor loan that carries a 1.35x factor rate ($2.835 million note), a 4% origination fee, a $250,000 minimum cash covenant, and a waterfall handing 100% of ATM net proceeds to the lender until $1.0 million is repaid. That structure means future equity sales largely go to the creditor rather than the business. Revenue of $282,881 in the quarter does not come close to covering $6.2 million of quarterly operating expense.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 52.5% of the 204 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.68%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CODX was trading at $0.29 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7M. The 52-week trading range was $0.25 to $13.54. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.